4 de April de 2025
Related content
Newsletter
Newsletter Life Sciences
The fifth edition of our newsletter brings regulatory updates on public health, health safety, and product regulation. One of the...
Life Sciences
See more
Newsletter
Newsletter Life Sciences
In April, Anvisa approved the first vaccine against Chikungunya in Brazil, expanding the tools available to combat the disease. It...
Life Sciences
See more
Newsletter
Newsletter Life Sciences
Check out the 3rd edition of the Life Sciences newsletter with the regulatory highlights in the health sector. The main...
Life Sciences
See more
Newsletter
Newsletter | Life Sciences
The Brazilian health sector is undergoing constant regulatory changes that directly impact the daily work of companies, professionals, and public...
Life Sciences
See more
Article
Normative ruling on essential safety and performance requirements for medical devices enters into force
By Sotiz Rizo, André Lins and Bernadete de Figueiredo Dias On September 4, 2024, RDC No. 848/2024 (“Resolution”) of the...
Life Sciences
See more
Article
Clinical Research: Anvisa creates Technical Chamber for Clinical Research on Medicines and Medical Devices
By Bruna Morais Conceição, André Lins e Bernadete de Figueiredo Dias On September 13, 2024, Joint Ordinance No. 2 of...
Life Sciences
See more